Coherent Market Insights published a business research report on Meningococcal Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Meningococcal Vaccines Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/3864
There are three meningococcal vaccines available in the US, including serogroup B meningococcal vaccine, meningococcal conjugate vaccine (MCV4), and meningococcal polysaccharide vaccine (MPSV4). The vaccine is given to children aged 11-12 years and booster doses are given to children at the age of 16. Meningococcal vaccine is required by international travellers for Hajj to Mecca, sub-Saharan Africa and other meningococcal outbreak areas.
Global Meningococcal Vaccines Market: Drivers
The global meningococcal vaccines market is likely to grow in the near term due to the growing number of pilgrims. For example, as per Travelport Worldwide Ltd, Asia Pacific made the largest increase in bookings of flight through the global delivery system at airports near Mecca in 2019, number of bookings with a 5% increase.
The size of the global meningococcal vaccines market was estimated to be expensed at US$ 2,965.9 Million in 2019 and over the estimated period (2020-2027) it is estimated to witness an expense of US$ 7,732.3 Million at a CAGR of 12.7%.
Global Meningococcal Vaccines Market: Opportunities
Research and Development associated to meningococcal vaccination can provide beneficial growth opportunities for market players. For example, researchers at The Children’s Hospital in Westmead, Australia, reported evaluating meningococcal vaccination among Hajj pilgrims in October 2019.
Global Meningococcal Vaccines Market: Restraints
Maintaining a cold chain for vaccine delivery increases the expense of vaccination, which is likely to impede market growth. Maintaining a cold chain (consisting of a series of refrigerators and ice-cold conductors with temperatures between 2°C and 8°C for storing vaccine) is a daunting task, delivering the vaccine to the individuals who need it, specifically in low- and middle-income country areas.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3864
Global Meningococcal Vaccines Market: Key Takeaways
The size of the global meningococcal vaccines market was estimated to be expensed at US$ 2,965.9 Million in 2019 and over the estimated period (2020-2027) it is estimated to witness an expense of US$ 7,732.3 Million at a CAGR of 12.7%. The key factors increasing the growth of the global meningococcal vaccines market over the approximate period are the growing rate of meningitis and government initiatives for increased vaccination.
In 2019, the conjugate vaccine segment is leading the global meningococcal vaccines market, considering 85.5% of the value. Approval of products for meningococcal conjugate vaccine individuals has supported departmental growth. For example, Pfizer Inc got approved by European Commission (EC) in December 2016, for an extended indication for pneumonic (meningococcal group A, C, W-135, and Y conjugate vaccines), indicated for active vaccination against invasive meningococcal disease (IMD).
In 2019, the private distribution sector leads the global meningococcal vaccines market, considering 81.3% in terms of value, then government distribution channels. Private vaccination centres charge for vaccines while government vaccine distribution centres provide free / low cost vaccines through various vaccination programs. This is likely to support the growth of the department over the approximate period.
Global Meningococcal Vaccines Market: Market Trends
Hajj pilgrims meanwhile miss the mandatory meningococcal vaccine. For example, in October 2019, as per a study published in MDPI Tropical Medicine and Infectious Diseases ‘Meningococcal Vaccine for Hajj Pilgrims: Predictors and Barriers’, Compliance 81.7% confirmed their meningococcal vaccination status, while 13.4% did not get the vaccine, and 4.8% were uncertain.
Many state governments in the US are commanding meningococcal vaccination. For example, in New Jersey, U.S. government mandated that college students be vaccinated against bacterial meningitis as a condition of enrolment in January 2020.
Global Meningococcal Vaccines Market: Canada Regulations
Health Canada introduced the recently approved 4CMenB vaccine in all regions in late 2013. The average price of the Novartis 4CMenB vaccine is higher, at US$ 100, but the compensate pattern is yet to be set up.
The Directorate of Biologics and Genetic Therapies, in joined forces with the Public Health Agency of Canada, conducts a pre-release trial that includes vaccine quality, safety and efficacy. After a detailed review of all the supporting data, the vaccine gets marketing approval.
Global Meningococcal Vaccines Market: Key Developments
September 2019: Baxter International Inc. Morgan Stanley attended the 17th Annual World Health Services Conference in New York, USA.
January 2020: GlaxoSmithKline PLC-funded study ‘Meningococcal B-vaccine and meningococcal carriage in adolescents in Australia’, published in the New England Journal of Medicine, reports that 4CMenB vaccine has no effect on male carcinogens. In Australian adolescents.
Global Meningococcal Vaccines Market: Competitive Landscape
Key players performing in the global meningococcal vaccines market are Serum Institute of India Ltd., Sanofi SA, Pfizer Inc., Novartis International AG., JN-International Medical Corporation, GlaxoSmithKline plc, Biomed Pvt Ltd., and Baxter International Inc.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3864
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Meningococcal Vaccines Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Meningococcal Vaccines Industry Impact
Chapter 2 Global Meningococcal Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Meningococcal Vaccines (Volume and Value) by Type
2.3 Global Meningococcal Vaccines (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Meningococcal Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Meningococcal Vaccines Market Analysis
Chapter 6 East Asia Meningococcal Vaccines Market Analysis
Chapter 7 Europe Meningococcal Vaccines Market Analysis
Chapter 8 South Asia Meningococcal Vaccines Market Analysis
Chapter 9 Southeast Asia Meningococcal Vaccines Market Analysis
Chapter 10 Middle East Meningococcal Vaccines Market Analysis
Chapter 11 Africa Meningococcal Vaccines Market Analysis
Chapter 12 Oceania Meningococcal Vaccines Market Analysis
Chapter 13 South America Meningococcal Vaccines Market Analysis
Chapter 14 Company Profiles and Key Figures in Meningococcal Vaccines Business
Chapter 15 Global Meningococcal Vaccines Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837